A new study shows that higher doses of radiation do not improve survival for many patients with prostate cancer, compared with the standard radiation treatment. The analysis, which included 104 radiation therapy oncology groups across North America, was led by researchers at the School of Medicine.
Proposed rules surrounding Medicaid recipients would affect a far smaller proportion of Missouri’s population than other states with similar legislation, according to research from the Center for Health Economics and Policy at Washington University in St. Louis.
Research from a collaborative team at Washington University in St. Louis tested a 3-D method that could lead to new diagnostic tools that will precisely measure the third-trimester growth and folding patterns of a baby’s brain. Their findings might help to sound an early alarm on developmental disorders in preemies that could affect them later in life.
Despite public health campaigns aimed at reducing unnecessary prescriptions for antibiotics, the drugs continue to be prescribed at startlingly high rates in outpatient settings such as clinics and physician offices, according to a new School of Medicine study.
A new School of Medicine study indicates that gut microbes influence the severity of parasitic worm infections in developing countries. The findings suggest that manipulating the gut’s microbial communities may offer protection.
A small clinical trial led by Richard S. Hotchkiss, MD, at the School of Medicine, shows that a drug that revs up the immune system holds promise in treating sepsis. The approach goes against the grain of earlier strategies that have relied on antibiotics and inflammatory medications to tamp down the immune system.
School of Medicine researchers report they found a way to treat urinary tract infections without using antibiotics, at least in mice. The scientists are working on an alternative that would prevent bacteria from causing disease.
Scientists at the School of Medicine have used the gene-editing technology CRISPR to engineer human T cells that can attack human T cell cancers without succumbing to friendly fire. The study evaluating the approach in mice appears online in the journal Leukemia.
Colin Nichols, the Carl F. Cori Professor of Cell Biology and Physiology, has received a grant to study how the genetic mutations underlying Cantu syndrome are linked to cardiovascular disease.
A research team from the School of Medicine led by Allan Doctor, MD, has received $5 million in grants to develop artificial red blood cells to act as a blood substitute. The research aims to prevent deaths from traumatic bleeding.